Developments in antimicrobial resistance and treatment

On World Health Day (7 April 2011), the WHO urged rapid and concerted action to safeguard today's antimicrobial drug treatments against resistance, and published a package of policies for governments and their national partners to combat the growing threat. So the timing could not have been bet...

Full description

Saved in:

Bibliographic Details
Published in:	Future microbiology Vol. 6; no. 7; p. 715
Main Author:	Bryan, Jenny
Format:	Journal Article
Language:	English
Published:	England 01-07-2011
Subjects:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Bacteria - drug effects Bacterial Infections - drug therapy Bacterial Infections - epidemiology Bacterial Infections - microbiology Community-Acquired Infections - drug therapy Community-Acquired Infections - epidemiology Community-Acquired Infections - microbiology Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - microbiology Drug Resistance, Multiple, Bacterial Drug Therapy - methods Drug Therapy - standards Humans
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	On World Health Day (7 April 2011), the WHO urged rapid and concerted action to safeguard today's antimicrobial drug treatments against resistance, and published a package of policies for governments and their national partners to combat the growing threat. So the timing could not have been better for leading scientists and researchers to discuss the latest developments in antimicrobial resistance and treatment at this year's International Symposium on Antimicrobial Agents and Resistance, held in a region of the world - Asia-Pacific - that is facing some of the greatest challenges from extended-spectrum β-lactamase-producing bacteria.
ISSN:	1746-0921
DOI:	10.2217/fmb.11.57